91 related articles for article (PubMed ID: 2472373)
1. Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage?
Ben-Ezra J; Winberg CD; Wu A; Rappaport H
Hematol Pathol; 1987; 1(3):147-56. PubMed ID: 2472373
[TBL] [Abstract][Full Text] [Related]
2. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.
Ikushima S; Yoshihara T; Matsumura T; Misawa S; Morioka Y; Hibi S; Imashuku S
Int J Hematol; 1991 Oct; 54(5):395-403. PubMed ID: 1721853
[TBL] [Abstract][Full Text] [Related]
5. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
6. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
7. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
8. Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.
Kimura N; Takihara Y; Akiyoshi T; Yoshida T; Ohshima K; Kawara T; Hisano S; Kozuru M; Okumura M; Kikuchi M
Cancer Res; 1989 Aug; 49(16):4488-92. PubMed ID: 2501027
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.
Ha K; Minden M; Hozumi N; Gelfand EW
J Clin Invest; 1984 Apr; 73(4):1232-6. PubMed ID: 6423668
[TBL] [Abstract][Full Text] [Related]
10. Human T cell gamma-chain gene rearrangements in acute lymphoid and nonlymphoid leukemia: comparison with the T cell receptor beta-chain gene.
Greenberg JM; Quertermous T; Seidman JG; Kersey JH
J Immunol; 1986 Sep; 137(6):2043-9. PubMed ID: 3489046
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
[TBL] [Abstract][Full Text] [Related]
13. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
14. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
[TBL] [Abstract][Full Text] [Related]
15. Gamma and delta chain gene rearrangement of T cell receptor in acute lymphoblastic leukemia.
Tong JH; Dong S; Chen Y; Qian ZZ; Gu LJ; Zhang YM; Wang ZY; Chen SJ; Chen Z
Chin Med J (Engl); 1994 Jan; 107(1):12-8. PubMed ID: 8187567
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
Altman AJ
Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of acute undifferentiated leukemia at the immunoglobulin and T-cell receptor genes level.
Hara J; Kawa-Ha K; Yumura K; Ishihara S; Doi S; Yabuuchi H; Konishi S; Nishikawa A
Jpn J Cancer Res; 1987 Feb; 78(2):170-5. PubMed ID: 3104260
[TBL] [Abstract][Full Text] [Related]
18. T-cell receptor gamma chain gene rearrangement in acute myelogenous leukemia--evidence for lymphoid lineage prematurity.
Lee MS; Chang KS; Trujillo JM; McCredie KB; Keating MJ; Freireich EJ; Stass SA
Hematol Pathol; 1987; 1(2):93-8. PubMed ID: 2848796
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of immunocytochemical detection of myeloperoxidase in undifferentiated and biphenotypic acute leukemias.
Musto P; Cascavilla N; Melillo L; Matera R; Carotenuto M
Haematologica; 1991; 76(5):434-6. PubMed ID: 1666891
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
